[Protective immune responses against HIV/SIV by live attenuated vaccine in non-human primate models].

Research output: Research - peer-reviewArticle

Abstract

Live attenuated simian immunodeficiency virus (SIV) vaccines (LAVs) are currently the most effective vaccines in nonhuman primate models for AIDS, yet the basis of their robust protection remains poorly understood. Our recent immune correlate study revealed that degree of protection against pathogenic SIV challenge strongly correlated with the SIV-specific CD4+ and CD8+ T cell responses in the lymph node but neither with the responses of such T cells in the peripheral blood and mucosal tissues nor with humoral immune responses. Interestingly, the maintenance of protective T cell responses in the lymph node was associated with the amount of persistent LAV replication in the lymph node, which localized almost exclusively in follicular helper T cells. The protected monkeys manifested greater magnitude of functional effector CD8+ T cells in the lymph node, suggesting that the induction and maintenance of antiviral effector memory T cells derived by persistent antigen production have a vital role in establishment of protection. This article reviews the mechanisms of the protection in monkeys vaccinated with LAV and their implication for development of successful AIDS vaccine.

LanguageEnglish (US)
Pages167-174
Number of pages8
JournalUirusu
Volume62
Issue number2
StatePublished - 2012

Fingerprint

Simian Immunodeficiency Virus
Attenuated Vaccines
Primates
HIV
T-Lymphocytes
Lymph Nodes
Haplorhini
Vaccines
Maintenance
AIDS Vaccines
Humoral Immunity
Helper-Inducer T-Lymphocytes
Antiviral Agents
Mucous Membrane
Acquired Immunodeficiency Syndrome
Antigens

ASJC Scopus subject areas

  • Medicine(all)

Cite this

[Protective immune responses against HIV/SIV by live attenuated vaccine in non-human primate models]. / Fukazawa, Yoshinori.

In: Uirusu, Vol. 62, No. 2, 2012, p. 167-174.

Research output: Research - peer-reviewArticle

@article{eda70a1068c9462c9bf8c7fd5f587848,
title = "[Protective immune responses against HIV/SIV by live attenuated vaccine in non-human primate models].",
abstract = "Live attenuated simian immunodeficiency virus (SIV) vaccines (LAVs) are currently the most effective vaccines in nonhuman primate models for AIDS, yet the basis of their robust protection remains poorly understood. Our recent immune correlate study revealed that degree of protection against pathogenic SIV challenge strongly correlated with the SIV-specific CD4+ and CD8+ T cell responses in the lymph node but neither with the responses of such T cells in the peripheral blood and mucosal tissues nor with humoral immune responses. Interestingly, the maintenance of protective T cell responses in the lymph node was associated with the amount of persistent LAV replication in the lymph node, which localized almost exclusively in follicular helper T cells. The protected monkeys manifested greater magnitude of functional effector CD8+ T cells in the lymph node, suggesting that the induction and maintenance of antiviral effector memory T cells derived by persistent antigen production have a vital role in establishment of protection. This article reviews the mechanisms of the protection in monkeys vaccinated with LAV and their implication for development of successful AIDS vaccine.",
author = "Yoshinori Fukazawa",
year = "2012",
volume = "62",
pages = "167--174",
journal = "Uirusu. Journal of virology",
issn = "0042-6857",
publisher = "Nihon Uirusu Gakkal/Japanese Society for Virology",
number = "2",

}

TY - JOUR

T1 - [Protective immune responses against HIV/SIV by live attenuated vaccine in non-human primate models].

AU - Fukazawa,Yoshinori

PY - 2012

Y1 - 2012

N2 - Live attenuated simian immunodeficiency virus (SIV) vaccines (LAVs) are currently the most effective vaccines in nonhuman primate models for AIDS, yet the basis of their robust protection remains poorly understood. Our recent immune correlate study revealed that degree of protection against pathogenic SIV challenge strongly correlated with the SIV-specific CD4+ and CD8+ T cell responses in the lymph node but neither with the responses of such T cells in the peripheral blood and mucosal tissues nor with humoral immune responses. Interestingly, the maintenance of protective T cell responses in the lymph node was associated with the amount of persistent LAV replication in the lymph node, which localized almost exclusively in follicular helper T cells. The protected monkeys manifested greater magnitude of functional effector CD8+ T cells in the lymph node, suggesting that the induction and maintenance of antiviral effector memory T cells derived by persistent antigen production have a vital role in establishment of protection. This article reviews the mechanisms of the protection in monkeys vaccinated with LAV and their implication for development of successful AIDS vaccine.

AB - Live attenuated simian immunodeficiency virus (SIV) vaccines (LAVs) are currently the most effective vaccines in nonhuman primate models for AIDS, yet the basis of their robust protection remains poorly understood. Our recent immune correlate study revealed that degree of protection against pathogenic SIV challenge strongly correlated with the SIV-specific CD4+ and CD8+ T cell responses in the lymph node but neither with the responses of such T cells in the peripheral blood and mucosal tissues nor with humoral immune responses. Interestingly, the maintenance of protective T cell responses in the lymph node was associated with the amount of persistent LAV replication in the lymph node, which localized almost exclusively in follicular helper T cells. The protected monkeys manifested greater magnitude of functional effector CD8+ T cells in the lymph node, suggesting that the induction and maintenance of antiviral effector memory T cells derived by persistent antigen production have a vital role in establishment of protection. This article reviews the mechanisms of the protection in monkeys vaccinated with LAV and their implication for development of successful AIDS vaccine.

UR - http://www.scopus.com/inward/record.url?scp=84907186239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907186239&partnerID=8YFLogxK

M3 - Article

VL - 62

SP - 167

EP - 174

JO - Uirusu. Journal of virology

T2 - Uirusu. Journal of virology

JF - Uirusu. Journal of virology

SN - 0042-6857

IS - 2

ER -